Kymera Therapeutics, Inc. Profile Avatar - Palmy Investing

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages …

Biotechnology
US, Watertown [HQ]

News

Theses · Events · Sentiments
End of KYMR's Analysis
CIK: 1815442 CUSIP: 501575104 ISIN: US5015751044 LEI: - UEI: -
Secondary Listings
KYMR has no secondary listings inside our databases.